SARS-CoV-2: recommendations for treatment in intensive care medicine
- PDF / 346,818 Bytes
- 7 Pages / 595 x 842 pts (A4) Page_size
- 91 Downloads / 210 Views
Wien Klin Wochenschr https://doi.org/10.1007/s00508-020-01734-6 Editor Mag. Volkmar Weilguni
SARS-CoV-2: recommendations for treatment in intensive care medicine Markus Köstenberger · Walter Hasibeder · Daniel Dankl · Reinhard Germann · Christoph Hörmann · Michael Joannidis · Klaus Markstaller · Steve-Oliver Müller-Muttonen · Stefan Neuwersch-Sommeregger · Eva Schaden · Thomas Staudinger · Roman Ullrich · Andreas Valentin · Rudolf Likar
Received: 20 May 2020 / Accepted: 11 August 2020 © Springer-Verlag GmbH Austria, part of Springer Nature 2020
Summary Coronavirus disease 2019 (COVID-19) progresses mildly in most of the cases; however, about 5% of the patients develop a severe acute respiratory distress syndrome (ARDS). Of all COVID-19 patients 3% need intensive care treatment, which becomes a great challenge for anesthesiology and intensive care medicine, medically, hygienically and for technical safety requirements. For these reasons, only experienced medical and nursing staff in the smallest grouping possible should be assigned. For these team members, a consistent use of personal protective equipment (PPE) is essential. Due to the immense medical challenges, the following treatment guidelines were developed by the ÖGARI (Österreichische Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin), FASIM (Federation of Austrian Societies of Intensive Care Medicine) and ÖGIAIN (Österreichische Gesellschaft
für Internistische und Allgemeine Intensivmedizin und Notfallmedizin). The recommendations given in this article are to be understood as short snapshots of the moment; all basic guidelines are works in progress and will be regularly updated as evidence levels, new study results and additional experience are gathered.
Dr. M. Köstenberger () · Dr. S. Neuwersch-Sommeregger · Prim. Univ.-Prof. Dr. R. Likar Department of Anaesthesiology and Critical Care Medicine, Klinikum Klagenfurt am Wörthersee, Feschnigstraße 11, 9020 Klagenfurt am Wörthersee, Austria [email protected]
Univ.-Prof. Dr. M. Joannidis University Hospital Innsbruck, Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria
Prim. Univ.-Prof. Dr. W. Hasibeder Department of Anaesthesiology and Critical Care Medicine, Hospital Zams, Zams, Austria Dr. D. Dankl Department of Anaesthesiology and Critical Care Medicine, University Hospital Salzburg, Salzburg, Austria Prim. Univ.-Doz. Dr. R. Germann Department of Anaesthesiology and Critical Care Medicine, Hospital Feldkirch, Feldkirch, Austria Prim. Assoc. Prof. Dr. C. Hörmann Department of Anaesthesiology an Critical Care Medicine, University Hospital St. Pölten, St. Pölten, Austria
K
Keywords SARS-CoV-2 · COVID-19 · ARDS · Personal protective equipment · Respiratory therapy
Introduction The recommended procedures for the prognosis, admission, diagnosis and treatment management described in this paper are based on the “ICU Therapy Guidelines for the Treatment of Patients with a SARS
Univ.-Prof. Dr. K. Ma
Data Loading...
